[NUVA] NuVasive, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Dental Instruments

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 66.29 Change: 0.51 (0.78%)
Ext. hours: Change: 0 (0%)

chart NUVA

Refresh chart

Strongest Trends Summary For NUVA

NUVA is in the medium-term down -30% in 2 months and down -36% in 4 months. In the long-term up 109% in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company?s principal product offering includes a minimally disruptive surgical platform, known Maximum Access Surgery (MAS) that includes its proprietary software-driven nerve detection and avoidance systems, NVM5 and NVJJB, and intra-operative monitoring (IOM) support; MaXcess, an integrated split-blade retractor system; and various specialized implants. Its spine surgery product line offerings comprise products for the thoracolumbar and the cervical spine, which are primarily used to enable access to the spine and to perform restorative and fusion procedures in a minimally disruptive fashion. The company?s biologic product line offerings used to aid the spinal fusion process or bone healing consist of allograft (donated human tissue); Osteocel Plus, an allograft cellular matrix containing via

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 6.84% Sales Growth - Q/Q5.47% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA3.69% ROE7.11% ROI4.18%
Current Ratio5.17 Quick Ratio3.93 Long Term Debt/Equity0.67 Debt Ratio0.2
Gross Margin76.15% Operating Margin15.49% Net Profit Margin6.01% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities-26.25 M Cash From Investing Activities-72.14 M Cash From Operating Activities35.18 M Gross Profit154.5 M
Net Profit10.27 M Operating Profit25.86 M Total Assets1.29 B Total Current Assets684.33 M
Total Current Liabilities132.44 M Total Debt368.5 M Total Liabilities618.32 M Total Revenue202.91 M
Technical Data
High 52 week71.41 Low 52 week44.53 Last close44.53 Last change0%
RSI24.85 Average true range2.17 Beta1 Volume185.56 K
Simple moving average 20 days-11.38% Simple moving average 50 days-20.45% Simple moving average 200 days-23.47%
Performance Data
Performance Week-8.13% Performance Month-20.65% Performance Quart-36.09% Performance Half-17.26%
Performance Year-19.85% Performance Year-to-date-10.15% Volatility daily2.6% Volatility weekly5.81%
Volatility monthly11.91% Volatility yearly41.26% Relative Volume231.69% Average Volume742.72 K
New High New Low

News

2019-01-15 08:06:15 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-01-11 12:24:19 | Tamarack Capital Management’s Return, AUM, and Holdings

2019-01-10 08:12:12 | Did NuVasive, Inc. NASDAQ:NUVA Insiders Buy Up More Shares?

2019-01-10 08:03:02 | Why Globus Medical Stock Rose 10% on January 9

2019-01-09 08:06:55 | See what the IHS Markit Score report has to say about NuVasive Inc.

2019-01-07 17:20:00 | Stocks making the biggest moves after hours: Union Pacific, Lennar and more

2019-01-07 08:30:00 | NuVasive Announces Preliminary Unaudited Fourth Quarter And Full Year 2018 Revenue Results

2019-01-03 09:07:02 | Solid Global Business Aids NuVasive Amid Pricing Pressure

2019-01-03 08:30:00 | NuVasive CEO J. Christopher Barry Announces New Organizational Structure And Leadership Team

2018-12-27 16:05:00 | NuVasive To Participate In 37th Annual J.P. Morgan Healthcare Conference

2018-12-21 08:06:15 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-12-20 08:06:44 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-12-19 18:24:59 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-12-14 03:32:17 | NuVasive, Inc. NUVA: Are Hedge Funds Right About This Stock?

2018-12-13 08:07:15 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-12-12 08:27:01 | NuVasive's Monolith Corpectomy System Ok'd for Expanded Use

2018-12-11 09:23:16 | Is There Now An Opportunity In NuVasive, Inc. NASDAQ:NUVA?

2018-12-11 08:07:15 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-12-11 07:45:00 | New Research Coverage Highlights Facebook, Korn/Ferry International, NuVasive, Sonic Automotive, B Communications, and Marin Software — Consolidated Revenues, Company Growth, and Expectations for 2018

2018-12-10 08:30:00 | NuVasive Grows Cervical Spinal Interbody Portfolio With PEEK Corpectomy Implant

2018-12-06 08:07:18 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-12-04 08:06:46 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-11-30 08:07:13 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-11-29 09:31:02 | NuVasive NUVA Up 11% Since Last Earnings Report: Can It Continue?

2018-11-28 08:07:14 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-11-27 08:07:18 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-11-24 08:07:17 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-11-19 16:05:00 | NuVasive To Participate In The 30th Annual Piper Jaffray Healthcare Conference

2018-11-15 09:09:02 | NuVasive Porous PEEK Implant OK'd for Use in XLIF Procedure

2018-11-15 08:30:00 | NuVasive Launches First-Of-Its-Kind Brigade® Lateral Implant And Instrumentation Optimized For Lateral Anterior Lumbar Interbody Fusion Spine Surgery

2018-11-15 08:06:46 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-11-08 16:05:00 | NuVasive's Proprietary Porous PEEK™ Implant To Be Used In Flagship XLIF® Procedure

2018-11-02 08:55:00 | New Research: Key Drivers of Growth for Edison International, NuVasive, LogMein, Anika Therapeutics, First Industrial Realty Trust, and ON Semiconductor — Factors of Influence, Major Initiatives and Sustained Production

2018-10-31 12:59:00 | Why NuVasive, Inc. Stock Is Sinking Today

2018-10-31 10:55:02 | NuVasive NUVA Q3 Earnings Lag Estimates, Revenues Top Mark

2018-10-31 08:03:00 | NuVasive Makes a Big Bet for 2019

2018-10-31 00:03:48 | Edited Transcript of NUVA earnings conference call or presentation 30-Oct-18 8:30pm GMT

2018-10-30 20:18:46 | NuVasive Inc NUVA Q3 2018 Earnings Conference Call Transcript

2018-10-30 17:55:09 | NuVasive NUVA Q3 Earnings Miss Estimates

2018-10-30 16:52:01 | NuVasive: 3Q Earnings Snapshot

2018-10-30 16:02:00 | NuVasive Reports Third Quarter 2018 Financial Results

2018-10-29 13:18:52 | 1 Extraordinary Investor, Plus a 5-Stock Sampler Annual Check-In

2018-10-19 13:02:00 | NuVasive's stock tumble on CEO departure presents buying opportunity, analyst says

2018-10-19 08:42:00 | NuVasive CEO Lucier to step down, names Chris Barry as successor

2018-10-19 08:30:00 | NuVasive Names J. Christopher Barry To Succeed Gregory T. Lucier As Chief Executive Officer; Lucier To Remain Chairman Of The Board

2018-10-17 11:38:22 | 5 Great Stocks You've Never Heard Of: 1 Year Later, Should You Be Glad We Told You About Them?

2018-10-16 08:07:14 | See what the IHS Markit Score report has to say about NuVasive Inc.

2018-10-12 08:51:31 | How Does NuVasive Inc’s NASDAQ:NUVA Earnings Growth Stack Up Against Industry Performance?

2018-10-11 16:05:00 | NuVasive Announces Conference Call And Webcast Of Third Quarter 2018 Results

2018-10-09 02:30:00 | NuVasive Announces Strategic Partnership With Biedermann Technologies To Access Intellectual Property And Co-Develop State-of-the-Art Complex Spine Solutions